White House Drug Strategy Clashes with Trump Administration's Recent Policy Moves
The White House unveiled a new drug strategy emphasizing naloxone, medication-assisted treatment, and fentanyl test strips. However, recent actions by...
The White House unveiled a new drug strategy emphasizing naloxone, medication-assisted treatment, and fentanyl test strips. However, recent actions by...
The FDA has granted expedited review to three experimental psychedelic drugs, including psilocybin for depression, under the Trump administration’s pr...